Maternal levels of endocrine disruptors, polybrominated diphenyl ethers, in early pregnancy are not associated with lower birth weight in the Canadian birth cohort GESTE

Abstract: Background: Polybrominated diphenyl ethers are known endocrine disrupting environmental contaminants used as flame retardants. Their levels have increased in humans over the last ten years, raising concerns about their consequences on human health. Some animal studies suggest that PBDEs can affect fetal growth; however, the results of human studies are contradictory. This study evaluates the association between the most common PBDEs in maternal blood measured in early pregnancy and birth weight. Methods: BDE-47, BDE-99, BDE-100 and BDE-153 levels were measured in 349 women during their first prenatal care visit at the University Hospital Center of Sherbrooke (Quebec, Canada). Birth weight and relevant medical information were collected from medical records. In contrast with previous studies, we examined the full range of clinical risk factors known to affect fetal growth as potential confounders, as well as other environmental pollutants that are likely to interact with fetal growth (polychlorinated biphenyls (PCBs), mercury, lead, cadmium and manganese). Results: There was no statistically significant relationship between PBDE levels in early pregnancy and birth weight in both unadjusted and multivariate regression models. Conclusions: Our results suggest that PBDEs in early pregnancy have little or no direct impact on birth weight, at least at the levels of exposure in our population

A global research priority agenda to advance public health responses to fatty liver disease

Background & aims An estimated 38% of adults worldwide have non-alcoholic fatty liver disease (NAFLD). From individual impacts to widespread public health and economic consequences, the implications of this disease are profound. This study aimed to develop an aligned, prioritised fatty liver disease research agenda for the global health community. Methods Nine co-chairs drafted initial research priorities, subsequently reviewed by 40 core authors and debated during a three-day in-person meeting. Following a Delphi methodology, over two rounds, a large panel (R1 n = 344, R2 n = 288) reviewed the priorities, via Qualtrics XM, indicating agreement using a four-point Likert-scale and providing written feedback. The core group revised the draft priorities between rounds. In R2, panellists also ranked the priorities within six domains: epidemiology, models of care, treatment and care, education and awareness, patient and community perspectives, and leadership and public health policy. Results The consensus-built fatty liver disease research agenda encompasses 28 priorities. The mean percentage of ‘agree’ responses increased from 78.3 in R1 to 81.1 in R2. Five priorities received unanimous combined agreement (‘agree’ + ‘somewhat agree’); the remaining 23 priorities had >90% combined agreement. While all but one of the priorities exhibited at least a super-majority of agreement (>66.7% ‘agree’), 13 priorities had 90% combined agreement. Conclusions Adopting this multidisciplinary consensus-built research priorities agenda can deliver a step-change in addressing fatty liver disease, mitigating against its individual and societal harms and proactively altering its natural history through prevention, identification, treatment, and care. This agenda should catalyse the global health community’s efforts to advance and accelerate responses to this widespread and fast-growing public health threat. Impact and implications An estimated 38% of adults and 13% of children and adolescents worldwide have fatty liver disease, making it the most prevalent liver disease in history. Despite substantial scientific progress in the past three decades, the burden continues to grow, with an urgent need to advance understanding of how to prevent, manage, and treat the disease. Through a global consensus process, a multidisciplinary group agreed on 28 research priorities covering a broad range of themes, from disease burden, treatment, and health system responses to awareness and policy. The findings have relevance for clinical and non-clinical researchers as well as funders working on fatty liver disease and non-communicable diseases more broadly, setting out a prioritised, ranked research agenda for turning the tide on this fast-growing public health threat

Variation in natural exposure to anopheles mosquitoes and its effects on malaria transmission

Contains fulltext : 187807.pdf (publisher's version ) (Open Access

Quantifying and Valuing Community Health Worker Time in Improving Access to Malaria Diagnosis and Treatment

This work was supported by the UNICEF/UNDP/World Bank/WHO/Special Programme for Research & Training in Tropical Diseases, World Health Organization, Geneva, Switzerland (project ID number A80553 [Burkina Faso]; A80550 [Nigeria]; and A80556 [Uganda]) through funds made available by the European Commission (FP7) for research to improve community access to health interventions in Africa

Diagnosis of crop secondary and micro-nutrient deficiencies in sub-Saharan Africa

Published online: 10 Jan 2019Crop production in sub-Saharan Africa has numerous biotic and abiotic constraints, including nutrient deficiencies. Information on crop response to macronutrients is relatively abundant compared with secondary and micronutrients (SMN). Data from 1339 trial replicates of 280 field trials conducted from 2013 to 2016 in 11 countries were analyzed for the diagnosis of SMN deficiencies. The diagnostic data included relative yield response (RYR) and soil and foliar test results. The RYR to application of a combination of Mg, S, Zn, and B (Mg–S–Zn–B) relative to a comparable N–P–K treatment was a > 5% increase for 35% of the legume blocks and 60% of the non-legume blocks. The frequencies of soil test Zn, Cu, and B being below their critical level were 28, 2 and 10% for eastern and southern Africa, respectively, and 55, 58 and 89% for western Africa, while low levels for other SMN were less frequent. The frequency of foliar results indicating low availability were 58% for Zn, 16% for S and less for other SMN. The r2 values for relationships between soil test, foliar test and RYR results were < 0.035 with little complementarity except for soil test Zn and B with cassava (Manihot esculenta L. Crantz) RYR in Ghana, and foliar Zn with cereal RYR in Uganda. Positive RYR is powerful diagnostic information and indicative of good profit potential for well-targeted and well-specified SMN application. Geo-referenced RYR, soil analysis and foliar analysis results for diagnosis of SMN deficiencies in 11 countries of sub-Saharan Africa were generally not complementary

Impact of Improving Community-Based Access to Malaria Diagnosis and Treatment on Household Costs

Financial support. This work was supported by UNICEF/UNDP/World Bank/WHO/Special Programme for Research & Training in Tropical Diseases, World Health Organization, Geneva, Switzerland (project ID numbers A80553; [;Burkina Faso], A80550; [;Nigeria], and A80556; [Uganda]) through funds made available by the European Commission (FP7) for research to improved community access to health interventions in Africa. Supplement sponsorship. This article appears as part of the supplement “Malaria in Highly Endemic Areas: Improving Control Through Diagnosis, Artemisinin Combination Therapy, and Rectal Artesunate Treatment,” sponsored by the World Health Organization